Using human APOE*3-Leiden.CETP transgenic mice that develop all the hallmarks of human NASH when placed on a high-fat Western diet [38], we found that oral administration of Oxy210 over 16 weeks significantly ameliorated NASH symptoms in these mice [37]. The gene discussed is APOE; the disease is metabolic dysfunction-associated steatohepatitis.